Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (77223) 77223
Book Review (11189) 11189
Publication (8535) 8535
Newsletter (5473) 5473
Book Chapter (727) 727
Newspaper Article (504) 504
Conference Proceeding (260) 260
Book / eBook (217) 217
Dissertation (116) 116
Magazine Article (97) 97
Government Document (66) 66
Transcript (44) 44
Trade Publication Article (21) 21
Reference (14) 14
Data Set (12) 12
Web Resource (8) 8
Journal / eJournal (5) 5
Report (5) 5
Streaming Video (4) 4
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (66294) 66294
animals (41020) 41020
humans (40442) 40442
antibodies (22317) 22317
immunology (20977) 20977
mice (19588) 19588
female (19079) 19079
male (13764) 13764
virology (11966) 11966
vaccines (11110) 11110
viruses (10433) 10433
neutralization tests (10017) 10017
monoclonal antibodies (9247) 9247
research (9133) 9133
health aspects (9099) 9099
infection (9047) 9047
proteins (8687) 8687
antibodies, viral - blood (8445) 8445
viral antibodies (8427) 8427
vaccination (8265) 8265
infectious diseases (8253) 8253
immunization (7471) 7471
adult (7394) 7394
medicine, research & experimental (7288) 7288
analysis (7122) 7122
enzyme-linked immunosorbent assay (7028) 7028
microbiology (6817) 6817
infections (6786) 6786
mice, inbred balb c (6562) 6562
neutralizing antibodies (6551) 6551
antigens (6548) 6548
antibodies, viral - immunology (6041) 6041
molecular sequence data (5813) 5813
monoclonal-antibodies (5740) 5740
virus diseases (5634) 5634
middle aged (5570) 5570
vaccine (5540) 5540
expression (5534) 5534
antibodies, monoclonal - immunology (5484) 5484
amino acid sequence (5434) 5434
immunoglobulins (5412) 5412
cell line (5364) 5364
abridged index medicus (5281) 5281
veterinary sciences (4875) 4875
biochemistry & molecular biology (4858) 4858
medical research (4720) 4720
immune response (4668) 4668
article (4635) 4635
multidisciplinary sciences (4630) 4630
hiv (4622) 4622
immunity (4579) 4579
immunogenicity (4525) 4525
antibody (4371) 4371
research article (4305) 4305
biotechnology & applied microbiology (4293) 4293
antibodies, neutralizing - immunology (4198) 4198
cells, cultured (4033) 4033
medicine (3959) 3959
pharmacology & pharmacy (3926) 3926
cell biology (3850) 3850
disease models, animal (3776) 3776
hiv-1 - immunology (3714) 3714
viral vaccines - immunology (3679) 3679
cells (3628) 3628
monoclonal-antibody (3524) 3524
cancer (3498) 3498
adolescent (3479) 3479
mice, inbred c57bl (3448) 3448
disease (3379) 3379
cytokines (3362) 3362
oncology (3306) 3306
antibodies, monoclonal - therapeutic use (3273) 3273
allergy and immunology (3210) 3210
aged (3123) 3123
physiological aspects (3111) 3111
epitopes (3097) 3097
cattle (3075) 3075
t cells (3068) 3068
care and treatment (3067) 3067
gene expression (3002) 3002
aids/hiv (2978) 2978
antigenic determinants (2972) 2972
antibodies, neutralizing - blood (2958) 2958
epitopes - immunology (2952) 2952
influenza (2947) 2947
medicine, experimental (2944) 2944
in-vivo (2895) 2895
time factors (2883) 2883
science (2881) 2881
biology (2854) 2854
rats (2848) 2848
child (2836) 2836
protein (2836) 2836
viral envelope proteins - immunology (2833) 2833
immunoglobulin g (2809) 2809
lymphocytes (2783) 2783
antibody formation (2769) 2769
antibodies, viral - analysis (2756) 2756
virus (2741) 2741
identification (2737) 2737
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (152) 152
Online Resources - Online (13) 13
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
UofT at Mississauga - Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
UTL at Downsview - May be requested (4) 4
UofT at Scarborough - Stacks (4) 4
Chemistry (A D Allen) - Stacks (3) 3
Earth Sciences (Noranda) - Stacks (3) 3
Engineering & Comp. Sci. - Stacks (3) 3
Gerstein Science - Circulation Desk (2) 2
Humber River Regional Hospital - Church Stacks (1) 1
Mt Sinai Hospital - Pathology (1) 1
New College (Ivey) - Stacks (1) 1
Scarborough Hospital - General (1) 1
Toronto East General Hospital - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (82790) 82790
Russian (250) 250
Chinese (230) 230
German (212) 212
French (173) 173
Japanese (171) 171
Spanish (111) 111
Italian (68) 68
Portuguese (62) 62
Korean (31) 31
Czech (28) 28
Bulgarian (24) 24
Polish (20) 20
Slovak (12) 12
Romanian (8) 8
Turkish (8) 8
Hungarian (7) 7
Dutch (6) 6
Ukrainian (5) 5
Croatian (3) 3
Danish (2) 2
Slovenian (2) 2
Swedish (2) 2
Indonesian (1) 1
Lithuanian (1) 1
Persian (1) 1
Serbian (1) 1
Vietnamese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Human Circulating PD-1+CXCR3−CXCR5+ Memory Tfh Cells Are Highly Functional and Correlate with Broadly Neutralizing HIV Antibody Responses
by Locci, Michela and Havenar-Daughton, Colin and Landais, Elise and Wu, Jennifer and Kroenke, Mark A and Arlehamn, Cecilia L and Su, Laura F and Cubas, Rafael and Davis, Mark M and Sette, Alessandro and Haddad, Elias K and Poignard, Pascal and Crotty, Shane and Int AIDS Vaccine Initiative Protoc and International AIDS Vaccine Initiative Protocol C Principal Investigators
Immunity, ISSN 1074-7613, 10/2013, Volume 39, Issue 4, pp. 758 - 769
The vast majority of currently licensed human vaccines work on the basis of long-term protective antibody responses. It is now conceivable that an... 
B-CELLS | T-FOLLICULAR HELPER | COMMITMENT | BCL6 | PROTECTION | DYNAMICS | REGULATORS | IMMUNOLOGY | EXPRESSION | PROGRAM | LYMPHOCYTES | Germinal Center - immunology | Humans | Molecular Sequence Data | Gene Expression Profiling | T-Lymphocytes, Helper-Inducer - virology | HIV Infections - immunology | HIV Infections - pathology | Immunity, Humoral | T-Lymphocytes, Helper-Inducer - immunology | B-Lymphocytes - virology | HIV Antibodies - biosynthesis | T-Lymphocytes, Helper-Inducer - pathology | B-Lymphocytes - pathology | Amino Acid Sequence | Gene Expression | Receptors, CXCR5 - genetics | Signal Transduction | HIV Infections - virology | Germinal Center - pathology | Receptors, CXCR5 - immunology | HIV-1 - immunology | B-Lymphocytes - immunology | Antibodies, Neutralizing - biosynthesis | Germinal Center - virology | Receptors, CXCR3 - genetics | Receptors, CXCR3 - immunology | Immunologic Memory | Programmed Cell Death 1 Receptor - immunology | Programmed Cell Death 1 Receptor - genetics | Antigens | Hypotheses | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Infections | Vaccines | Mutation | Gene expression | Viral infections | Immune system | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Crystal Structures of Ricin Toxin's Enzymatic Subunit (RTA) in Complex with Neutralizing and Non-Neutralizing Single-Chain Antibodies
by Rudolph, Michael J and Vance, David J and Cheung, Jonah and Franklin, Matthew C and Burshteyn, Fiana and Cassidy, Michael S and Gary, Ebony N and Herrera, Cristina and Shoemaker, Charles B and Mantis, Nicholas J and Brookhaven National Laboratory (BNL)
Journal of Molecular Biology, ISSN 0022-2836, 08/2014, Volume 426, Issue 17, pp. 3057 - 3068
Ricin is a select agent toxin and a member of the RNA -glycosidase family of medically important plant and bacterial ribosome-inactivating proteins. In this... 
antibody | nanobody | neutralizing | toxin | MECHANISM | A-CHAIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | VACCINE | MONOCLONAL-ANTIBODY | B-CELL EPITOPES | IN-VITRO | EUKARYOTIC RIBOSOMES | IMMUNOTOXIN | MICE | RIBOSOME-INACTIVATING PROTEINS | Amino Acid Sequence | Camelus | Protein Structure, Secondary | Models, Molecular | Molecular Sequence Data | Crystallography, X-Ray | Castor Bean - enzymology | Animals | Hydrogen Bonding | Ricin - chemistry | Antibodies, Neutralizing - chemistry | Protein Structure, Quaternary | Protein Binding | Protein Interaction Domains and Motifs | Ricin - antagonists & inhibitors | Single-Chain Antibodies - chemistry | Enzymes | RNA | Crystals | Lectins | Monoclonal antibodies | Structure | Antigenic determinants | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO® ) induced neutralizing antibody titers
by Van Gessel, Yvonne and Klade, Christoph S and Putnak, Robert and Formica, Alessandra and Krasaesub, Somporn and Spruth, Martin and Cena, Bruno and Tungtaeng, Anchalee and Gettayacamin, Montip and Dewasthaly, Shailesh
Vaccine, ISSN 0264-410X, 2011, Volume 29, Issue 35, pp. 5925 - 5931
Abstract Immune sera from volunteers vaccinated in a blinded Phase 3 clinical trial with JE-VAX® and a new Japanese encephalitis virus (JEV) vaccine (IC51 or... 
Allergy and Immunology | Ixiaro | Correlation | Vaccine | Protection | Japanese encephalitis | UNITED-STATES | MEDICINE, RESEARCH & EXPERIMENTAL | CELLS | GENOTYPE | PHYLOGENETIC ANALYSIS | IMMUNOLOGY | IMMUNIZATION | CHALLENGE | ASIA | MICE | POINTS | Japanese Encephalitis Vaccines - administration & dosage | Immune Sera - immunology | Immunization | Encephalitis, Japanese - virology | Humans | Immune Sera - administration & dosage | Japanese Encephalitis Vaccines - immunology | Male | Neutralization Tests | Treatment Outcome | Antibodies, Viral - blood | Mice, Inbred ICR | Animals | Encephalitis, Japanese - prevention & control | Encephalitis, Japanese - immunology | Survival Analysis | Immunization, Passive | Female | Mice | Encephalitis Virus, Japanese - pathogenicity | Antibodies, Neutralizing - blood | Encephalitis Virus, Japanese - immunology | Encephalitis, Japanese - mortality | Virus diseases | Vaccines | Vaccination | Cell culture | Automation | Dilution | Brain research | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
by Bootz, Anna and Karbach, Astrid and Spindler, Johannes and Kropff, Barbara and Reuter, Nina and Sticht, Heinrich and Winkler, Thomas H and Britt, William J and Mach, Michael
PLoS Pathogens, ISSN 1553-7366, 08/2017, Volume 13, Issue 8, pp. e1006601 - e1006601
Human cytomegalovirus (HCMV) is an important, ubiquitous pathogen that causes severe clinical disease in immunocompromised individuals, such as organ... 
PROGENITOR CELLS | BACTERIAL ARTIFICIAL CHROMOSOME | VACCINE | TO-CELL SPREAD | MICROBIOLOGY | GUINEA-PIGS | SALIVARY-GLANDS | REPLICATION | VIROLOGY | MICE | CMV INFECTION | MONOCLONAL-ANTIBODIES | PARASITOLOGY | Cytomegalovirus - immunology | Antibodies, Neutralizing - immunology | Animals | Antibodies, Viral - immunology | Viral Envelope Proteins - immunology | Cytomegalovirus Infections - immunology | Mice | Cytomegalovirus Vaccines - immunology | Real-Time Polymerase Chain Reaction | Antibodies, Monoclonal - immunology | Disease Models, Animal | Cytomegaloviruses | Physiological aspects | Causes of | Monoclonal antibodies | Glycoproteins | Research | Health aspects | Antigens | Cytomegalovirus | Neurosciences | Immunoglobulins | Glycoprotein B | Toxicity | Funding | Immunodeficiency | Glycoprotein | Viruses | Data processing | Infections | Infants | Disease control | Chemotherapy | Immunology | Immunotherapy | Neutralizing | Biocompatibility | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
by Keane, Joseph and Gershon, Sharon and Wise, Robert P and Mirabile-Levens, Elizabeth and Kasznica, John and Schwieterman, William D and Siegel, Jeffrey N and Braun, M. Miles
The New England Journal of Medicine, ISSN 0028-4793, 10/2001, Volume 345, Issue 15, pp. 1098 - 1104
Infliximab, a humanized antibody against tumor necrosis factor α (TNF-α), is used to treat rheumatoid arthritis and Crohn's disease. The Food and Drug... 
Recurrence | Lung - pathology | Adverse Drug Reaction Reporting Systems | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Tuberculosis - chemically induced | Tuberculosis - immunology | Infliximab | Arthritis, Rheumatoid - drug therapy | Crohn Disease - drug therapy | Adolescent | Aged, 80 and over | Adult | Female | Aged | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Tuberculosis - pathology | infliximab | tumor necrosis factor-^a | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc gamma R interactions for protection against influenza virus in vivo
by DiLillo, DJ and Tan, GS and Palese, P and Ravetch, JV
NATURE MEDICINE, ISSN 1078-8956, 02/2014, Volume 20, Issue 2, pp. 143 - 151
Neutralizing antibodies against influenza viruses have traditionally been thought to provide protection exclusively through their variable region; the... 
MEDICINE, RESEARCH & EXPERIMENTAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | IMMUNOGLOBULIN | MONOCLONAL-ANTIBODY | IDENTIFICATION | INDUCED CONFORMATIONAL-CHANGES | CELL BIOLOGY | DEPENDENT CELLULAR CYTOTOXICITY | IMMUNE-RESPONSES | UNIVERSAL VACCINE | RECEPTOR-BINDING | CONSTANT-REGION | ANTIGEN | Influenza A Virus, H1N1 Subtype - immunology | Surface Plasmon Resonance | Cell Line | Enzyme-Linked Immunosorbent Assay | Humans | Mice, Inbred C57BL | Antibodies, Neutralizing - metabolism | Kaplan-Meier Estimate | Neutralization Tests | Hemagglutinin Glycoproteins, Influenza Virus - immunology | Receptors, IgG - immunology | Chick Embryo | Receptors, IgG - metabolism | Mice, Knockout | Antibodies, Neutralizing - immunology | Animals | Dogs | Killer Cells, Natural - immunology | Mice | Antibodies, Monoclonal - metabolism | Antigen-Antibody Complex - immunology | Antibodies, Monoclonal - immunology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection
by Henry Dunand, Carole J and Leon, Paul E and Huang, Min and Choi, Angela and Chromikova, Veronika and Ho, Irvin Y and Tan, Gene S and Cruz, John and Hirsh, Ariana and Zheng, Nai-Ying and Mullarkey, Caitlin E and Ennis, Francis A and Terajima, Masanori and Treanor, John J and Topham, David J and Subbarao, Kanta and Palese, Peter and Krammer, Florian and Wilson, Patrick C
Cell Host & Microbe, ISSN 1931-3128, 06/2016, Volume 19, Issue 6, pp. 800 - 813
Pathogenic H7N9 avian influenza viruses continue to represent a public health concern, and several candidate vaccines are currently being developed. It is... 
DEPENDENT CELLULAR CYTOTOXICITY | TRIAL | RESPONSES | H5N1 | DOMAIN | VIROLOGY | A VIRUSES | MICROBIOLOGY | VIRUS VACCINE | INFECTION | PARASITOLOGY | Orthomyxoviridae Infections - prevention & control | Antibodies, Monoclonal - biosynthesis | Humans | Hemagglutinin Glycoproteins, Influenza Virus - immunology | Influenza A Virus, H7N9 Subtype - immunology | Antigens, Viral - immunology | Influenza Vaccines - pharmacology | Antibodies, Neutralizing - immunology | Animals | Influenza Vaccines - immunology | Dogs | HEK293 Cells | Madin Darby Canine Kidney Cells | Antibodies, Viral - immunology | Female | Influenza, Human - virology | Mice | Mice, Inbred BALB C | Influenza, Human - prevention & control | Orthomyxoviridae Infections - virology | Antibodies, Monoclonal - immunology | Orthomyxoviridae Infections - immunology | Disease Models, Animal | Influenza, Human - immunology | Influenza viruses | Influenza vaccines | Animal experimentation | Avian influenza | Medical colleges | Vaccination | Lectins | Monoclonal antibodies | Biopharmaceutics | Antigenic determinants | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
by Caskey, Marina and Klein, Florian and Lorenzi, Julio C. C and Seaman, Michael S and West, Anthony P and Buckley, Noreen and Kremer, Gisela and Nogueira, Lilian and Braunschweig, Malte and Scheid, Johannes F and Horwitz, Joshua A and Shimeliovich, Irina and Ben-Avraham, Sivan and Witmer-Pack, Maggi and Platten, Martin and Lehmann, Clara and Burke, Leah A and Hawthorne, Thomas and Gorelick, Robert J and Walker, Bruce D and Keler, Tibor and Gulick, Roy M and Fätkenheuer, Gerd and Schlesinger, Sarah J and Nussenzweig, Michel C
Nature, ISSN 0028-0836, 06/2015, Volume 522, Issue 7557, pp. 487 - 491
HIV-1 immunotherapy with a combination of first generation monoclonal antibodies was largely ineffective in pre-clinical and clinical settings and was... 
THERAPY | VIRUS | HIV-1 NEUTRALIZATION | GENETIC-DETERMINANTS | IMMUNOTHERAPY | MULTIDISCIPLINARY SCIENCES | PASSIVE TRANSFER | IN-VIVO | VACCINE | MICE | MONOCLONAL-ANTIBODIES | Antibodies, Neutralizing - administration & dosage | Humans | Middle Aged | Viremia - therapy | Molecular Sequence Data | Antibodies, Monoclonal - therapeutic use | Male | Case-Control Studies | HIV Envelope Protein gp120 - immunology | Young Adult | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - adverse effects | HIV Antibodies - immunology | Time Factors | HIV-1 - chemistry | Antibodies, Neutralizing - therapeutic use | Adult | Antibodies, Neutralizing - adverse effects | Female | HIV Antibodies - therapeutic use | HIV Envelope Protein gp120 - chemistry | HIV Antibodies - pharmacology | Binding Sites | Antibodies, Monoclonal - immunology | Amino Acid Sequence | Immunization, Passive - methods | HIV-1 - drug effects | HIV Infections - virology | Antibodies, Monoclonal - pharmacokinetics | Antibodies, Neutralizing - pharmacology | HIV Antibodies - administration & dosage | Viral Load - immunology | HIV-1 - immunology | Viremia - virology | Antibodies, Monoclonal - administration & dosage | HIV Infections - therapy | Viremia - immunology | Viral Load - drug effects | CD4 Antigens - metabolism | Evolution, Molecular | Viral antibodies | Virus diseases | Physiological aspects | Antibodies | HIV infection | Antigens | Immunoglobulins | Human immunodeficiency virus--HIV | Immunotherapy | Infections | Drug dosages | Binding sites | Immune system | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
by Doria-Rose, Nicole A and Schramm, Chaim A and Gorman, Jason and Moore, Penny L and Bhiman, Jinal N and Dekosky, Brandon J and Ernandes, Michael J and Georgiev, Ivelin S and Kim, Helen J and Pancera, Marie and Staupe, Ryan P and Altae-Tran, Han R and Bailer, Robert T and Crooks, Ema T and Cupo, Albert and z, Aliaksan and Garrett, Nigel J and Hoi, Kam H and Kong, Rui and Louder, Mark K and Longo, Nancy S and McKee, Krisha and Nonyane, Molati and O'Dell, Sijy and Roark, Ryan S and Rudicell, Rebecca S and Schmidt, Stephen D and Sheward, Daniel J and Soto, Cinque and Wibmer, Constantinos Kurt and Yang, Yongping and Zhang, Zhenhai and Mullikin, James C and Binley, James M and Sanders, Rogier W and Wilson, Ian A and Moore, John P and Ward, Anew B and Georgiou, George and Williamson, Carolyn and Abdool Karim, Salim S and Morris, Lynn and Kwong, Peter D and Shapiro, Lawrence and Mascola, John R and Becker, Jesse and Benjamin, Betty and Blakesley, Robert and Bouffard, Gerry and Brooks, Shelise and Coleman, Holly and Dekhtyar, Mila and Gregory, Michael and Guan, Xiaobin and Gupta, Jyoti and Han, Joel and Hargrove, April and Ho, Shi-ling and Johnson, Taccara and Legaspi, Richelle and Lovett, Sean and Maduro, Quino and Masiello, Cathy and Maskeri, Baishali and McDowell, Jenny and Montemayor, Casana and Mullikin, James and Park, Morgan and Riebow, Nancy and Schandler, Karen and Schmidt, Brian and Sison, Christina and Stantripop, Mal and Thomas, James and Thomas, Pam and Vemulapalli, Meg and Young, Alice and NISC Comparative Sequencing and NISC Comparative Sequencing Program
Nature, ISSN 0028-0836, 2014, Volume 509, Issue 7498, pp. 55 - 62
Antibodies capable of neutralizing HIV-1 often target variable regions 1 and 2 (V1V2) of the HIV-1 envelope, but the mechanism of their elicitation has been... 
B-CELLS | MAXIMUM-LIKELIHOOD | STRUCTURAL BASIS | HIV-1-NEUTRALIZING ANTIBODIES | MULTIDISCIPLINARY SCIENCES | IMMUNODEFICIENCY-VIRUS TYPE-1 | VACCINE EFFICACY | INFECTION | BROAD | HUMAN MONOCLONAL-ANTIBODIES | ENVELOPE TRIMER | Complementarity Determining Regions - genetics | Epitope Mapping | Epitopes, B-Lymphocyte - chemistry | Humans | AIDS Vaccines - immunology | Molecular Sequence Data | Antibody Affinity - immunology | Neutralization Tests | Epitopes, B-Lymphocyte - immunology | HIV Antibodies - isolation & purification | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - immunology | HIV Envelope Protein gp160 - chemistry | Complementarity Determining Regions - chemistry | HIV-1 - chemistry | Binding Sites - immunology | B-Lymphocytes - metabolism | Protein Structure, Tertiary | Amino Acid Sequence | CD4 Antigens - immunology | B-Lymphocytes - cytology | Models, Molecular | Antibody Affinity - genetics | Antibodies, Neutralizing - genetics | HIV Antibodies - chemistry | AIDS Vaccines - chemistry | Antibodies, Neutralizing - isolation & purification | Cell Lineage | HIV-1 - immunology | B-Lymphocytes - immunology | Antibodies, Neutralizing - chemistry | Complementarity Determining Regions - immunology | HIV Envelope Protein gp160 - immunology | HIV Antibodies - genetics | Somatic Hypermutation, Immunoglobulin - genetics | CD4 Antigens - metabolism | Evolution, Molecular | Viral antibodies | Antigen-antibody reactions | AIDS vaccines | AIDS (Disease) | Antibodies | Physiological aspects | Research | AIDS research | Cell culture | Genes | Human immunodeficiency virus--HIV | Phylogenetics | Amino acids | Infections | Genomes | Mutation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights